Beta interferons improve survival in people with MS
Beta interferons improve survival in patients with relapsing-onset multiple sclerosis when used for at least three years, research has shown.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Multiple Sclerosis